Open Access Article
Yaoping
Liu‡
ab,
Joshua J.
Raymond‡
b,
Xiaolin
Wu‡
b,
Patrina Wei Lin
Chua
a,
Sharon Yan Han
Ling
a,
Chia Ching
Chan
a,
Cheryl
Chan
b,
Joanne Xin Yi
Loh
b,
Melody Xing Yen
Song
c,
Matilda Yu Yan
Ong
c,
Peiying
Ho
a,
Megan E.
Mcbee
a,
Stacy L.
Springs
bd,
Hanry
Yu
bef and
Jongyoon
Han
*abdgh
aAntiMicrobial Resistance (AMR) IRG, Singapore-MIT Alliance for Research and Technology (SMART), 138602, Singapore
bCritical Analytics for Manufacturing Personalized-Medicine (CAMP) IRG, Singapore-MIT Alliance for Research and Technology (SMART), 138602, Singapore
cSchool of Life Sciences & Chemical Technology, Ngee Ann Polytechnic, 599489, Singapore
dCenter for Biomedical Innovation, Massachusetts Institute of Technology (MIT), MA 02139, USA
eInstitute of Bioengineering and Bioimaging (IBB), A*STAR, 138632, Singapore
fDepartment of physiology and WisDM and Mechanobiology Institute, National University of Singapore, 119077, Singapore
gDepartment of Electrical Engineering and Computer Science, MIT, Cambridge, MA 02139, USA
hDepartment of Biological Engineering, MIT, Cambridge, MA 02139, USA. E-mail: jyhan@mit.edu
First published on 19th August 2024
Rapid and sensitive detection of pathogens in various samples is crucial for disease diagnosis, environmental surveillance, as well as food and water safety monitoring. However, the low abundance of pathogens (<10 CFU) in large volume (1 mL−1 L) samples containing vast backgrounds critically limits the sensitivity of even the most advanced techniques, such as digital PCR. Therefore, there is a critical need for sample preparation that can enrich low-abundance pathogens from complex and large-volume samples. This study develops an efficient electrostatic microfiltration (EM)-based sample preparation technique capable of processing ultra-large-volume (≥500 mL) samples at high throughput (≥10 mL min−1). This approach achieves a significant enrichment (>8000×) of extremely-low-abundance pathogens (down to level of 0.02 CFU mL−1, i.e., 10 CFU in 500 mL). Furthermore, EM-enabled sample preparation facilitates digital amplification techniques sensitively detecting broad pathogens, including bacteria, fungi, and viruses from various samples, in a rapid (≤3 h) sample-to-result workflow. Notably, the operational ease, portability, and compatibility/integrability with various downstream detection platforms highlight its great potential for widespread applications across diverse settings.
Commonly used downstream detection techniques (e.g., PCR, sequencing, etc.) are typically limited to assay volumes of no more than 100 μL. To achieve true positives in the detection of low-abundance samples with statistical significance, it is essential to minimize the standard deviation, which scales
in sampling of the n microbial cells.9 The standard deviation becomes substantial when n < 10, thereby, at least ∼10 microbial cells must be present in the processed 100 μL volume. Moreover, interference from the background often leads to false negatives or false positives. Therefore, there is an urgent need for sample preparation techniques aiming at separating and enriching low-abundance pathogens from vast backgrounds in raw samples to enhance the sensitivity and improve the detection limit of downstream methods.8,10–14
Over the past decades, various sample preparation techniques have been explored. While micro/nano techniques have gained attention for their efficiency and sensitivity in detection of low-concentration objects, there is still no effective microfluidic-based sample preparation due to low throughput (μL min−1 levels) and susceptibility to clogging when handling large-volume (mL–L) and complex samples.13,15,16 Current sample preparation techniques mainly include centrifugation/ultracentrifugation,17–19 immunomagnetic separation,20–23 enrichment culture methods,7,24–26 and filtration/ultrafiltration.27–32 Each method presents distinct advantages and limitations, necessitating consideration of factors such as sample characteristics, target pathogen, desired sensitivity levels, and downstream analysis requirements. Key performance metrics for evaluating a sample preparation technique include volume processing capacity (volume throughput), sensitivity (capture efficiency of targets), enrichment factor (the ratio of target abundance or sample volume pre- to post-processing), as well as labor and time requirements.
Centrifugation can process large-volume samples (up to ∼50 mL in typical laboratory systems) but is time-consuming and labor-intensive. It also suffers from significant loss of low-abundance pathogens and is challenging to effectively separate from background contents. Nevertheless, various centrifugation-based techniques, such as differential centrifugation,33 density gradient centrifugation,34 and ultracentrifugation,19 have been used for pathogen enrichment and purification. These methods facilitate the isolation of intact pathogens or pathogen-associated biomolecules, but their reliance on specialized and expensive reagents and equipment restrict the widespread adoption, particularly in resource-limited environments.
Immunomagnetic separation (IMS) utilizes magnetic beads conjugated with specific antibodies or ligands to selectively capture target pathogens from background contents in complex samples, enhancing the performance of downstream detection.20–23 However, IMS heavily relies on the availability of antibodies or ligands of high cost and limited accessibility for all pathogens, restricting its broad application. IMS also faces challenges in efficiently recovering captured pathogens from beads, potentially affecting downstream detection performance.
Enrichment culture optimizes conditions for low-abundance pathogen growth, amplifying their numbers for detection.7,24–26 While adaptable to various sample types and microbial species, enrichment culture is time-consuming (days to weeks) and may overlook non-culturable pathogens, leading to false negatives and incomplete pathogen diversity in the initial sample. Moreover, prolonged incubation may lead to excessive proliferation of non-target microorganisms, potentially obscuring or interfering with detection of low-abundance targets.
Filtration methods utilize a certain-sized pore to selectively capture pathogens based on their size, enabling the concentration of low-abundance pathogens from complex samples.27–32 These techniques often expedite the processing of large-volume samples and require much less equipment than centrifugation. However, traditional membrane filtration frequently encounters issues such as clogging and non-specific adhesion,32 leading to reduced efficiency in the capture and retention/recovery of pathogens, potentially degrading the sensitivity of downstream detection methods. Electrostatic membrane filtration, dating back to the 1960s, captures pathogens via electrostatic interactions between the charged membrane surface and inherent negative charges on the pathogen surface35–39 but suffers from inefficient retention/recovery of captured pathogens from the membrane.32,39 Membrane filtration can realize massive processing of up to liter-level samples, but the final retentate volume still falls within milliliter level, creating a gap with downstream detection platforms.28,30,37,38 Developing improved filtration units and increased enrichment fold are crucial for enhancing efficiency in electrostatic filtration processes and compatibility with downstream applications.
Herein, this work established an electrostatic microfiltration (EM)-based sample preparation for highly efficient enrichment of low-abundance pathogens from large-volume samples using the previously reported precise, efficient, rapid, flexible, easy, controllable and thin (PERFECT) filter,40 schematically shown in Fig. 1C–G. This approach involves coating the PERFECT filter with a biocompatible hydrogel, calcium (Ca)-alginate (generated by crosslinking alginic acid sodium salt and CaCl2), to impart positive charges for capturing negatively charged pathogens. The controllable degradation of Ca-alginate gel enables the efficient release, thereby, the concentration of captured pathogens into small volumes suitable for downstream techniques. With this efficient sample preparation, we can achieve several goals: 1) improved pathogen capture efficiency: EM processing significantly enhanced pathogen capture efficiency, contrasting with less effective outcomes using centrifugation/ultracentrifugation. 2) Release with high viability: controllable Ca-alginate degradation facilitated pathogen release with viability, confirmed through live-dead staining and subsequent successful cultivation on agar plates. 3) Capability for large-volume processing: EM demonstrated the ability to process ultra-large-volume samples at high throughput with high-fold enrichment. 4) Broad applicability: EM exhibited versatility in capturing low-abundance bacteria, fungi, and viruses in diverse matrices, showcasing adaptability across various microorganisms and sample compositions. 5) Rapid sample-to-result workflow: EM-based concentration interfacing digital amplification techniques enabled a rapid sample-to-result workflow and achieved remarkable improvements in the limit-of-detection (LOD) compared to centrifugation/ultracentrifugation-based sample preparation methods. This advancement facilitated the sensitive detection of various pathogens, including bacteria, fungi, and viruses. Additionally, the EM-based sample preparation demonstrated operational ease, portability, and compatibility with diverse downstream techniques, indicating its potential for widespread applications in different settings.
| Reagents | Final concentration |
|---|---|
| a Primer mix and probe can be either single-plex (one set) or multiplex (containing multiple sets) detection, with listed concentration applicable for one species. | |
| dLAMP for bacteria and fungi detection | |
| Isothermal amplification buffer (NEB, B0537S) | 1× |
| Taurine | 50 μM |
| Deoxynucleoside triphosphate, PCR grade (Roche, 03622614001) | 1.4 mM |
| Magnesium sulfate (MgSO4) solution (NEB, B1003S) | 6 mM |
| WarmStart RTx reverse transcriptase (NEB, M0380L) | 0.3 U μL−1 |
| RNase inhibitor, murine (NEB, M0314L) | 1 U μL−1 |
| Bst 2.0 WarmStart DNA polymerase (NEB, M0538M) | 1 U μL−1 |
| Reference dye (cyanine 680SE) | 250 nM |
| Primer mixa | 1.6 μM of FIP & BIP |
| 0.2 μM of F3 & B3 | |
| 0.4 μM of LoopF & LoopB | |
| Probea | 0.2 μM for bacteria |
| 0.275 μM for fungi | |
| Lysate | 0.2× |
| dPCR for virus detection | |
| PCR mastermix (sniper, RT017096A) | 1× |
| Primer mix | 0.25 μM of FP & RP |
| Probe | 0.5 μM |
| Lysate | 0.3× |
:
K. pneumoniae
:
P. aeruginosa at the level of 100
:
100
:
100 CFU mL−1 in 10 mL LB matrix were used.
000 g@10 minutes with the Avanti J-15R, Beckman Coulter, US), and ultracentrifugation for virus (20
000 rpm/63500 g@30 minutes at 4 °C with the Optima™ L-100 XP Ultracentrifuge, Beckman Coulter, US), and unconcentrated raw sampling approaches. The 10 mL LB-, BHIB- and FBS-related samples were repeated more than three times at each abundance level. Box chart analyses using Origin 2020b were conducted on the data collected from all repetitions, as illustrated in Fig. 3, 4A, 7C and D. Detailed information for each sample can be found in Tables S5–S7.† These box charts portray normalized signals correlated to normalized abundances, based on actual CFU counts and the categorization standard mentioned earlier. The detection of bottled water containing extremely low abundances of bacteria involved more than five repeats. Scatter plots displaying all data points are presented in Fig. 5, with comprehensive details available in Table S8.† For the 10 mL LB, BHIB and FBS single-plex spiked samples, the LOD was determined using the statistical variance assessed by Welch's t-test. When the signals of samples at a certain abundance are all higher than those from NC samples, the p-value below 0.05 signifies a significant distinction and substantiates the LOD. In the case of 100 mL and 500 mL bottled water samples, the limit of blank (LOB), calculated as Ave. + 1.645 × SD, was employed to differentiate between true positives and false negatives, and thereby calculating the detection rate.
The gravity-driven rapid EM processing, using a food dye as a color label for easy visualization and demonstration of the sample flow, is displayed in Fig. 1L. Fig. S1D–S1F† shows the packing of the EM-PERFECT filter, providing comprehensive views of the design and structure of the matching gadget purchased together with the PERFECT filter. The EM processing achieves a filtration throughput exceeding 10 mL min−1 (Fig. 1D), primarily attributed to the PERFECT filter's ultra-small thickness of approximately 5 μm (Fig. 1K) spanning a large area of 17 mm × 17 mm. Consequently, the transmembrane pressure of the filter, which decreases with the reduction of the liquid column height above the filter during filtration, is around 291 Pa at the beginning of filtration when using a 10 mL-PBS (aqueous) sample. Furthermore, after Ca-alginate gel coating, the filter's hydrophilicity slightly increased with the contact angle reducing from 76° to 68° (Fig. S2†), enhancing its filtration efficiency.
Additionally, in-parallel conventional centrifugation for bacteria concentration was conducted to assess and compare capture efficiencies of bacteria-spiked samples by introducing known quantities of bacteria into lysogeny broth (LB). Considering practicability for obtaining valid CFU counts, the capture efficiencies for three species across different abundances ranging from level of 10 CFU mL−1 to 1000 CFU mL−1 in a 10 mL volume are shown in Fig. 2F–H. Table S2† details the capture efficiencies and CFU counts for each species at different abundance levels. The capture efficiencies achieved by EM processing for all three bacterial species show a significant increase compared to conventional centrifugation. Across abundances from 10 CFU mL−1 to 1000 CFU mL−1, EM processing yielded capture efficiencies of at least 74 ± 6.0%, 64 ± 14.0%, and 68 ± 22.0%, in contrast to a maximum of 4.4 ± 0.5%, 18 ± 5.0%, and 12 ± 4.0% from centrifugation, for S. aureus, K. pneumoniae, P. aeruginosa, respectively. Particularly noteworthy is the 10 CFU mL−1 abundance level, where the capture efficiencies present remarkable increase by 31×, 8×, and 52× compared to those from centrifugation, for S. aureus, K. pneumoniae, P. aeruginosa, respectively. This emphasizes the substantial enhancement in capture efficiency achieved through EM processing, particularly at lower bacterial concentrations, compared to conventional centrifugation methods.
Concurrently, comparative studies were done using a conventional centrifugation for bacteria concentration and a raw sampling approach (collecting 40 μL from initial raw samples) side-by-side to evaluate the detection sensitivities and LODs (experimental workflow shown in Fig. S3†). These assessments involved single-plex spiked samples by introducing certain abundances of bacteria into 10 mL LB (Fig. 3), 10 mL fetal bovine serum (FBS) (Fig. 4), or 100 and 500 mL commercially available bottled water (Fig. 5). Additionally, multiplex spiked samples were tested to evaluate the detection of different pathogens at both balanced and biased abundance ratios to confirm the unbiased capture of various species via EM processing (Fig. 6).
![]() | ||
| Fig. 6 The dLAMP results from multiplex (S. aureus, K. pneumoniae, and P. aeruginosa) samples in various matrices: A–C) LB, D–F) FBS, and G–I) bottled water. | ||
Box charts of normalized dLAMP signals correlated with normalized abundances based on the earlier-mentioned categorization standard for the 10 mL LB samples are shown in Fig. 3. Table S5† shows raw data from dLAMP detection for the three bacteria across diverse abundances, and Fig. S3† presents scatter plots of dLAMP signals corresponding to CFU counts. When compared to the centrifugation-based sample preparation and unconcentrated raw sampling approach, the EM processing-enabled workflow shows significant enhancement of dLAMP signals. For instance, in the case of 100 CFU mL−1P. aeruginosa, signals increase by 25× and 200×, respectively. As a result, EM processing advances LODs by 1000× (from 1000 to 1 CFU mL−1), 100× (from 100 to 1 CFU mL−1) and 10× (from 10 to 1 CFU mL−1) for S. aureus, K. pneumoniae, and P. aeruginosa, respectively, compared to the centrifugation-based processing. Furthermore, an additional 10× improvement (i.e., 10
000×, 1000×, and 100× lower LODs, respectively) is achieved compared to the raw sampling approach. The remarkable improvement in dLAMP signals is fundamentally attributed to a substantial concentration increase achieved through a high-fold enrichment (167×, from 10 mL to 60 μL) following the high-efficiency capture of low-abundance pathogens in EM processing. The concentration increment is evident in the raw images and scatter plots of positive versus negative signal points/partitions from dLAMP running (Fig. S5†).
Moreover, the dLAMP method employed in this study effectively amplified and detected both 16S DNA and 16S rRNA during a 1-hour incubation at 60 °C, covering both reverse transcription and LAMP reactions. Despite the inherent characteristics of RNA, including instability and variable copy numbers, leading to relatively large variances in dLAMP signals at identical abundance levels, the higher copies of 16S rRNA contribute to enhancing detection sensitivity.
Noteworthily, the dLAMP signals of S. aureus are lower than those of K. pneumoniae and P. aeruginosa, which could be due to more challenging lysis of the thick and rigid cell walls of gram-positive species. The LOD could be further improved by optimizing the lysis protocol for difficult-to-lyse pathogens.
To further explore the performance of EM processing for samples with complex backgrounds, FBS was selected as a representative matrix with high-concentration (∼10 mg mL−1) protein for spiking tests. The preparation of the FBS spiked samples followed the same protocol as described earlier for LB spiked samples described earlier. However, a notable challenge with FBS lies in the inhibitory effect of high-concentration protein on the dLAMP reactions. Consequently, two approaches were undertaken in this study to address the inhibitor issue.
First, Pluronic F-127, widely used for restricting non-specific adhesion,41 was added into alginic acid sodium salt to craft a Plu-Ca-alginate gel on the surface of the PERFECT filter. This incorporation reduced protein adhesion onto the surface of the EM-PERFECT filter, enabling subsequent amplification of the signal outputs in downstream dLAMP reactions.
Second, recognizing that protein absorption onto the filter surface is concentration-dependent, a dilution-based concentration lowering was implemented to minimize protein adhesion. FBS samples were 10× diluted with 1× phosphate-buffered saline (PBS) before undergoing EM processing.
The results of FBS spiked samples are presented in Fig. 4 with raw dLAMP data listed in Table S6.† The data reveals robust positive detection signals for FBS samples. Despite signals of FBS samples being lower compared to LB samples, they exhibit statistical distinction from negative control (NC) samples, at the 10 CFU mL−1 level. This underscores the successful application of EM processing, even in challenging complex matrices with high-concentration protein background.
When expanding to various applications, the positive charges on the EM-PERFECT filter may adhere to the negatively charged objects in real-world samples, potentially causing clogging. To mitigate this issue, implementing additional sample preparation methods to remove non-pathogen backgrounds prior to EM processing is worth investigating. For instance, spiral microfluidics can efficiently separate host cells from pathogens in bloodborne pathogen detection but struggles with enrichment due to high-factor dilution from the large-volume sheath buffer input.12 By leveraging EM-PERFECT filter's advantageous volume processability, it is possible to enrich low-abundance pathogens from large-volume spiral outputs. This combination could enhance pathogen enrichment efficacy while reducing clogging from non-pathogen backgrounds.
Detection of low-abundance pathogens in ultra-large volume samples is a challenge and potential application of this technology. To evaluate the efficacy of the EM-based sample preparation method for this application, 100 mL and 500 mL commercially available bottled drinking water samples were spiked with approximately 10 CFU. The EM-based sample preparation method allowed for an enrichment factor of >8000× (from 500 mL to 60 μL).
As depicted in Fig. 5 and Table S8,† detection rates surpass 80% (4 out 5 samples) for both 100 mL and 500 mL volumes across the three investigated bacteria, although a few signals fall below the threshold defined by the limit of blank (LOB) signals. This achievement is particularly noteworthy as it demonstrates an unprecedented level of sensitivity, allowing detection of as low as 0.02 CFU mL−1 (i.e., 10 CFU in 500 mL) from initial samples with volume extending up to 500 mL. The ability to robustly detect pathogens at such low abundance in ultra-large volumes has barely been reported. This accomplishment establishes a new paradigm for rapid and sensitive detection, particularly in scenarios where liter-level samples containing extremely low-abundance pathogens pose significant risks.
In many samples, multiple bacteria or pathogens are present concurrently. Therefore, the detection of multiplex spiked samples of LB (Fig. 6A–C), FBS (Fig. 6D–F) and bottled drinking water (Fig. 6G–I) matrices were evaluated. These samples contained different pathogens at both balanced/equal and biased/unequal abundance ratios, with detailed data available in Tables S9–S11.† In multiplex samples featuring balanced abundance ratios, such as S. aureus, K. pneumoniae and P. aeruginosa each at ∼100 CFU mL−1 in 10 mL LB or FBS, and ∼10 CFU in 100 or 500 mL bottled water, the signals observed were indistinguishable from those in single-plex samples for all three species. For multiplex samples with biased abundance ratios, where S. aureus, K. pneumoniae and P. aeruginosa were present at ∼10 CFU mL−1, 100 CFU mL−1, and 100 CFU mL−1, respectively, in 10 mL LB or FBS, although the signals of S. aureus were lower compared to those from single-plex samples, they remained statistically distinct from signals in multiplex NC samples. Despite the inherent lower signals of S. aureus compared to K. pneumoniae and P. aeruginosa in single-plex samples, the ability to detect S. aureus, even amidst 10× higher-abundance other bacteria cells, underscores the robustness of EM-processing-based sample preparation across various samples containing different pathogens. This robustness is attributed to the universal capture efficiency of different pathogens in the EM-processing, a characteristic previously verified.
000 PFU mL−1 in 10 mL) via dLAMP and dPCR, respectively. Tables S7 and S12† provide detailed data from dLAMP and dPCR detection for C. albicans and HSV across diverse abundance levels, respectively.
The detection results in Fig. 7C and D demonstrate the capability of dLAMP and dPCR to detect low-abundance C. albicans and HSV, respectively. A LOD at 1 CFU mL−1 in 10 mL BHIB can be established for C. albicans. For viruses, the LOD for detection of viral spent media through EM-based sample preparation is significantly advanced by 10
000×, reaching 1 PFU mL−1 in 10 mL spent media, compared to ultracentrifugation-based virus concentration or raw sampling approach. Furthermore, it is noteworthy that ultracentrifugation is time-intensive (processing time @∼45 minutes), costly, and reliant on large equipment, making it much less competitive for broad applications.
These findings highlight the advantages of the EM-PERFECT filter in terms of rapidity, sensitivity, portability, operational ease, and integrability, indicating its immense potential for diverse applications across various settings. However, the dual nature of EM processing, which offers broad applicability for diverse microorganisms but lacks selectivity, presents both opportunities and challenges, particularly for samples with a high total load of pathogens but a minority of target pathogens.
Potential solutions for specific applications could be designed from two aspects. First, specific detection can be achieved through the design of downstream detection methods, such as primer design in PCR/dPCR-based detection or targeted sequencing. Second, the EM method can be combined with further selective capture techniques, such as affinity-based methods. Given the high-fold preconcentration, the input sample for downstream selective capture will be of small volume and high concentration, thereby enhancing binding efficiency and reducing costs (less consumption of beads/antibodies) in subsequent selective capture process.
The efficiency of the EM-enabled sample preparation is evident in its outstanding abilities: 1) capture of low-abundance pathogens: achieving efficiency of 63.85–73.73% and marking increase by 8–52× compared to conventional centrifugation methods, at the level of 10 CFU mL−1 for the three investigated bacterial species. 2) Release of high-viability pathogens: the controllable degradation of the positively charged layer facilitates the release of pathogenic cells with high viability (64.06% ± 9.94%–96.62% ± 1.65% for three species) and cultivability, enabling subsequent functional downstream analyses, such as antimicrobial susceptibility testing. 3) Processing ultra-large-volume samples with high-fold enrichment: handling samples of ≥500 mL at high throughput of ≥10 mL min−1 and demonstrating a remarkable enrichment factor >8000×. 4) Enhancing LODs: lowering the LODs of digital amplification detection methods by 10–10
000× for broad pathogens, including bacteria, fungi, and viruses, compared to centrifugation/ultracentrifugation methods. This includes showcasing detection at levels of 1 CFU mL−1 for diverse bacteria and fungi, and 1 PFU mL−1 for viruses, with a samples volume of 10 mL. 5) Rapid sample-to-result workflow: EM processing to the output of the digital amplification detection signals was executed rapidly (≤3 h), ensuring a significantly shorter turnaround time compared to other culture-based techniques.
This study stands as an impressive demonstration of detection capability (>80% detection rate) for broad pathogens from sample volumes extending up to 500 mL, with abundance as low as 0.02 CFU mL−1 (i.e., 10 CFU in 500 mL). Furthermore, the versatility of EM processing is noteworthy, as it demonstrates the capability to sensitively detect various pathogens, including bacteria, fungi, and viruses. Beyond its technical merits, the operational ease, portability, and compatibility/integrability with various downstream detection techniques highlight the potential of EM-based sample preparation for wide applications across diverse settings. By addressing the most critical bottleneck in pathogen detection, this work sets the stage for a transformative impact on various areas and diverse settings, including water and food safety monitoring, environmental surveillance, epidemiology, and disease diagnosis.
Footnotes |
| † Electronic supplementary information (ESI) available. See DOI: https://doi.org/10.1039/d4lc00419a |
| ‡ These authors contributed equally to this work. |
| This journal is © The Royal Society of Chemistry 2024 |